Dr. Ming-Chung Kan

Dr. Ming-Chung Kan，台湾Vaxsia公司创始人。他擅长于免疫学、细胞生物学、生物技术等方面。他曾著有《Analysis of CPEB Family Protein Member CPEB4 Function in Mammalian Neurons: A Dissertation 》，《RNAII transcribed by IPTG-induced T7 RNA polymerase is non-functional as a replication primer for ColE1-type plasmids in Escherichia coli 》等。他将受邀参加2017第九届世界疫苗大会。